Announcement

Collapse

Landmark HairMax LaserComb Clinical Study Results Published, Proving Efficacy and Safety In Treating Hair Loss

The results of 4 clinical studies conclusively proving the efficacy and safety of the HairMax LaserComb was published in a peer review medical journal in April 2014 and here is a summation of the article.

"The results of four clinical studies on the treatment of male and female pattern hair loss with the HairMax LaserComb, was just published today in a peer-review journal, The American Journal of Clinical Dermatology. The article, Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study was co-authored by renowned experts in the field of hair disorders. The results of these studies have now provided robust and conclusive evidence that the HairMax LaserComb is both effective and safe for the treatment of pattern hair loss in men and women.

This is the link to the clinical article:

http://link.springer.com/article/10....257-013-0060-6

The four clinical studies were conducted under strict Good Clinical Practice Guidelines at multiple study sites, including major teaching institutions of dermatology such as the Cleveland Clinic, University of Minnesota and University of Miami. Enrolled in the study were 225 males and females diagnosed with androgenetic alopecia (male and female pattern hair loss). Subjects received either the HairMax LaserComb or a sham (inactive) device in a randomized, blinded manner so that no one knew which device they were on. The primary efficacy analysis was based on the change in hair count after 26 weeks treatment with the HairMax LaserComb, compared to change in hair count with the sham (inactive) device.

The results of the studies showed that there was an average increase in terminal hair count of over 20 hairs per cm² (equivalent to over 139 hairs per square inch). Additionally, a higher percentage of lasercomb-treated subjects reported overall improvement in hair loss condition and thickness and fullness of hair in self-assessment, compared with sham-treated subjects. No serious adverse events were reported in any subject receiving the lasercomb in any of the studies.

The authors concluded that: “Our results suggest that low-level laser treatment may be an effective option to treat pattern hair loss in men and women”. They also concluded that “Low Level Laser Therapy [LLLT] may provide a promising treatment option for patients who do not respond to either finasteride or minoxidil, and who do not want to undergo hair transplantation.”

The authors also had this overall observation: “…… while topical minoxidil solution or foam is widely used to treat pattern hair loss and is generally well tolerated, the treatment needs to be applied one or twice daily, and be in contact with the scalp for at least 4 hours. Such application can be impractical for many users, leading to noncompliance and reduced efficacy. As an alternative, the lasercomb treatment is safe and easy to apply, with 8-15 minutes of treatment three times per week, and leaves no residue on the scalp. Such user friendliness of the lasercomb may lead to better patient compliance and improved efficacy.”

Dr. Lawrence Schachner, Chairman of the Department of Dermatology at the Miller School of Medicine of the University of Miami, and senior author of the article said: “The results of these clinical studies provide further evidence that the HairMax LaserComb may be utilized as an effective option for treating androgenetic alopecia in men and women.”

You can view a video of the lead author of the clinical paper, Dr. Lawrence Schachner and Dr. Joquin Jimenez discussing the clinical paper at this link: http://hairmaxpro.com/study-html/
See more
See less

was interested

Collapse
X
  •  
  • Filter
  • Time
  • Show
Clear All
new posts

  • was interested

    Hi, i just wana say that the photos that show the difference before and after using Hair max are actually very bad, and it does't prove any thing, some of them aren't even for the same person like photo number 5.
    So if u really think that ur product is working, at least put good photos that really show the difference this comb can make as u say.

  • #2
    Dear "Unregistered" User,

    Hello and thank you for your post. It's UNBELIEVABLE that no matter what photos are up, no matter the amount of success our product has had, no matter how long we have been on the market and finally no matter how long we guarantee our product, we run into skeptical, negative people like you!

    So you can continue to rely on photos to make a decision or you can do something about your hair condition now!

    Sonia
    Last edited by Sonia; 01-06-2006, 02:39 PM.

    Comment


    • #3
      All people are looking for is proof that the lasercomb isn't a scam and it indeed works. FDA approval is what everyone is waiting for but you guys dont do a very good job of keeping us up to date with that stuff. Atleast let us know if youre getting closer to knowing or if its out of your hands. We want to know!!!

      Comment


      • #4
        Clinical Trials Update

        Dear "Unregistered"

        As we have stated before (please see earlier postings), it would be inappropriate to discuss specific results of our clinical trials until the FDA has reviewed them. Unfortunately, the process has been even more demanding than we had anticipated. Due to the fact that our first study was declined (due to the trial design), it was essential that we be as thorough as possible to ensure that proper guidelines were followed.

        Our pending FDA application is of utmost importance to us, and for this reason, we have proceeded with extreme diligence. In light of this, we hired one of the top legal firms that handle FDA matters. We did not realize at the time just how comprehensive all of their requirements would be. For example, we had to perform software analysis; we had to send 100 units to a laboratory for extensive biocompatibility testing (cytotoxicity, sensitization, irritation/intracutaneous) as well as EMC testing; plus much more.

        However, we have completed the primary requirements and are more encouraged than ever, since the results have only reinforced our belief that we are offering the highest quality, most effective treatment on the market.

        Please understand that the collection and evaluation of statistics and technical information is a serious undertaking that requires significant time and effort. All of the data has been compiled, reviewed, and the final version is right now being submitted to the FDA. It is a very exciting time for us, but at the same time we must also be patient. The process is out of our hands and we must await an FDA response.

        Let me assure you that we are even more anxious to release our results than you are to see them.

        - Angela

        Comment

        Sorry, you are not authorized to view this page
        Working...
        X